112 related articles for article (PubMed ID: 38073490)
21. Constructing a cancer stem cell related prognostic model for predicting immune landscape and drug sensitivity in colorectal cancer.
Chen J; Wu S; Peng Y; Zhao Y; Dong Y; Ran F; Geng H; Zhang K; Li J; Huang S; Wang Z
Front Pharmacol; 2023; 14():1200017. PubMed ID: 37377935
[No Abstract] [Full Text] [Related]
22. Identification of cuproptosis-related subtypes and development of a prognostic signature in colorectal cancer.
Huang Y; Yin D; Wu L
Sci Rep; 2022 Oct; 12(1):17348. PubMed ID: 36253436
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA.
Cao L; Duan L; Zhang R; Yang W; Yang N; Huang W; Chen X; Wang N; Niu L; Zhou W; Chen J; Li Y; Zhang Y; Liu J; Fan D; Liu H
Hereditas; 2023 Mar; 160(1):10. PubMed ID: 36895014
[TBL] [Abstract][Full Text] [Related]
24. Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer.
Zhang J; Zhang H; Li F; Song Z; Li Y; Zhao T
BMC Med Genomics; 2020 Nov; 13(1):172. PubMed ID: 33198757
[TBL] [Abstract][Full Text] [Related]
25. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
Liang X; Cheng Z; Chen X; Li J
Front Genet; 2022; 13():955424. PubMed ID: 36046241
[No Abstract] [Full Text] [Related]
26. Predicting survival and immune microenvironment in colorectal cancer: a STAT signaling-related signature.
Zeng R; Wu H; Qiu X; Zhuo Z; Sha W; Chen H
QJM; 2022 Sep; 115(9):596-604. PubMed ID: 34978566
[TBL] [Abstract][Full Text] [Related]
27. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
28. An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients.
Shao Y; Jia H; Huang L; Li S; Wang C; Aikemu B; Yang G; Hong H; Yang X; Zhang S; Sun J; Zheng M
Front Oncol; 2021; 11():711776. PubMed ID: 34249766
[TBL] [Abstract][Full Text] [Related]
29. Role of ferroptosis-related genes in prognostic prediction and tumor immune microenvironment in colorectal carcinoma.
Yang C; Huang S; Cao F; Zheng Y
PeerJ; 2021; 9():e11745. PubMed ID: 34316400
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer.
Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y
BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429
[TBL] [Abstract][Full Text] [Related]
31. A five-immune-related genes-based prognostic signature for colorectal cancer.
Zhu L; Wang H; Wang Z
Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
[TBL] [Abstract][Full Text] [Related]
32. A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer.
Liu J; Yu F; Liu Z; Wang X; Li J
Cancer Biother Radiopharm; 2022 Dec; 37(10):963-975. PubMed ID: 34551265
[No Abstract] [Full Text] [Related]
33. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
Front Immunol; 2022; 13():994874. PubMed ID: 36330513
[TBL] [Abstract][Full Text] [Related]
34. Identification of a hypoxia-related gene prognostic signature in colorectal cancer based on bulk and single-cell RNA-seq.
Qiao Y; Jiang X; Li Y; Wang K; Chen R; Liu J; Du Y; Sun L; Li J
Sci Rep; 2023 Feb; 13(1):2503. PubMed ID: 36781976
[TBL] [Abstract][Full Text] [Related]
35. Construction and validation of stemness-related lncRNA pair signature for predicting prognosis in colorectal cancer.
Thandar M; Zhu Y; Zhang X; Chen Z; Zhao Y; Huang S; Chi P
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11815-11828. PubMed ID: 37410143
[TBL] [Abstract][Full Text] [Related]
36. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
[TBL] [Abstract][Full Text] [Related]
37. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes.
Wen S; He L; Zhong Z; Mi H; Liu F
Front Mol Biosci; 2020; 7():604252. PubMed ID: 33330631
[TBL] [Abstract][Full Text] [Related]
39. A novel identified pyroptosis-related prognostic signature of colorectal cancer.
Zheng C; Tan Z
Math Biosci Eng; 2021 Oct; 18(6):8783-8796. PubMed ID: 34814322
[TBL] [Abstract][Full Text] [Related]
40. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
